Pathfinder Awarded Qualifying Theraupetic Discovery Grant

Share Article

Pathfinder Therapeutics, Inc. receives grant to support ongoing clinical trials for Explorer, its image-guided surgery system. Explorer enables surgeons to accurately identify and deliver treatment for abdominal cancer.

Pathfinder Therapeutics, Inc. has been awarded $244,479.25 in grant funding from the IRS and Department of Health and Human Services under the Qualifying Therapeutic Discovery Project (QTDP).

QTDP was created as part of the Affordable Care Act in March, 2010 and is designed to assist companies that show significant potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs and advance the goal of curing cancer within the next 30 years.

“We are pleased to hear that the Department of Health and Human Services recognizes the potential benefits that Pathfinder’s innovative technology can provide for patients suffering from liver cancer,” said Skip Goode, CEO of Pathfinder. “This grant will allow us to further the development of Explorer, our surgical navigation platform designed for open and minimally invasive procedures.”

More information can be found at:

About Pathfinder Therapeutics, Inc.
Pathfinder Therapeutics, Inc. is a medical device company dedicated to increasing the number and effectiveness of surgeries on abdominal and other soft tissue organs. Pathfinder improves surgical precision by allowing surgeons to "see through" the organ they are operating on by registering the surgical instrument in three-dimensional space onto pre-operative patient medical images. Pathfinder is the first company to receive FDA clearance for a medical device to navigate liver surgery using preoperative medical images. The Explorer system uses state-of-the-art line of sight localization and surface registration techniques to show surgeons where they are in the context of their target organ and underlying structures. The Company is also developing an embodiment of Explorer to be used in minimally invasive surgical interventions in the liver. In addition to Explorer, Pathfinder has commercialized Scout, a software system for liver surgery planning. Beyond the liver, Pathfinder is developing guidance systems for the kidney, pancreas, and other organs. For more information, go to

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kara Phillip
Visit website